文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

中国阿尔茨海默病的成本及对全球成本的再估计。

The cost of Alzheimer's disease in China and re-estimation of costs worldwide.

机构信息

Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China; Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China; Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China; Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China; National Clinical Research Center for Geriatric Disorders, Beijing, China.

Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.

出版信息

Alzheimers Dement. 2018 Apr;14(4):483-491. doi: 10.1016/j.jalz.2017.12.006. Epub 2018 Feb 9.


DOI:10.1016/j.jalz.2017.12.006
PMID:29433981
Abstract

INTRODUCTION: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain. METHODS: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD. RESULTS: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015. DISCUSSION: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.

摘要

简介:中国阿尔茨海默病(AD)的社会经济成本及其对全球经济负担的影响尚不确定。

方法:我们从中国 81 个有代表性的中心的 3098 名 AD 患者中收集数据,并估计了 2015 年中国每位患者和所有患者的 AD 成本。基于这些数据,我们重新估算了全球 AD 的成本。

结果:2015 年每位患者的年社会经济成本为 19144.36 美元,总费用为 1677.40 亿美元。预计到 2030 年,年总成本将达到 5074.90 亿美元,到 2050 年将达到 18900 亿美元。根据我们的结果,2015 年全球痴呆症成本估计为 9575.60 亿美元,到 2030 年将达到 25400 亿美元,到 2050 年将达到 91200 亿美元,远高于《2015 年世界阿尔茨海默病报告》的预测。

讨论:中国承担着沉重的 AD 成本负担,这极大地改变了全球 AD 成本的估计。

相似文献

[1]
The cost of Alzheimer's disease in China and re-estimation of costs worldwide.

Alzheimers Dement. 2018-2-9

[2]
Associated Factors of Total Costs of Alzheimer's Disease: A Cluster-Randomized Observational Study in China.

J Alzheimers Dis. 2019

[3]
The US economic and social costs of Alzheimer's disease revisited.

Am J Public Health. 1994-8

[4]
Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.

BMC Neurol. 2017-1-25

[5]
Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.

Neurology. 2006-12-26

[6]
The Economic Burden of Alzheimer's Disease in Zhejiang Province.

J Alzheimers Dis. 2021

[7]
The Impact of Alzheimer's Disease on the Chinese Economy.

EBioMedicine. 2015-12-22

[8]
Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai, China.

J Alzheimers Dis. 2008-9

[9]
Estimating the costs of caring for people with Alzheimer disease in California: 2000-2040.

J Public Health Policy. 2001

[10]
The cost of Alzheimer's disease in managed care: a cross-sectional study.

Am J Manag Care. 1999-7

引用本文的文献

[1]
Artificial intelligence technologies for enhancing neurofunctionalities: a comprehensive review with applications in Alzheimer's disease research.

Front Aging Neurosci. 2025-8-15

[2]
Global Societal Burden of Alzheimer's Disease by Severity: a Targeted Literature Review.

Neurol Ther. 2025-8-27

[3]
Integrating neuroinflammation biomarkers into the ATN(X) framework: Advances in Alzheimer's pathogenesis, diagnosis, and insights from non-human primate models.

Alzheimers Dement. 2025-8

[4]
Adaptive immunity in the neuroinflammation of Alzheimer's disease.

Chin Med J (Engl). 2025-9-5

[5]
Mesenchymal stem cell application in Alzheimer's disease.

Regen Ther. 2025-7-26

[6]
Study on the Pharmacological Efficacy and Mechanism of Dual-Target Liposome Complex AD808 Against Alzheimer's Disease.

Pharmaceuticals (Basel). 2025-6-29

[7]
Identification and experimental validation of Alzheimer's disease hub genes via bioinformatics and machine learning.

J Alzheimers Dis Rep. 2025-7-15

[8]
Factors Associated with Acceptance of Screening and Knowledge About Dementia in Older Adults in China: A Cross-Sectional Study.

Healthcare (Basel). 2025-6-20

[9]
The rising burden of Alzheimer's and other dementias: role of high fasting plasma glucose from 1990 to 2021.

Front Med (Lausanne). 2025-6-26

[10]
Caring for Grandchildren and Dementia Among Older Adults in China.

JAMA Netw Open. 2025-7-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索